Abstract:Intermedin/Adrenomedullin 2 (IMD/AM2) is an endogenous peptide which is a member of calcitonin gene‐related peptide family (calsitonin, CGRPα, CGRPβ, adrenomedullin, amiline). Due to our previous findings, IMD/AM2 is a potent endothelium‐dependent and nitric oxide‐(NO) mediated vasodilator in pulmonary vascular bed (1, 2). It has been reported that ACh‐induced vasodilation is impaired in chronic hypoxia induced pulmonary hypertension (PHT) since hypoxia claimed to disrupt NO synthesis, release, and activity (3–5). Furthermore, NO‐dependent vasodilation pathways and its proteins may also alter due to hypoxia (6, 7). Therefore, we wondered whether IMD/AM2 is still responsive in PHT. For this purpose, adult male SD rats (300–350 g) were exposed to 3 weeks hypobaric hypoxia (Hacettepe University Animal Experimentations Local Ethics Board, 2015/02). In chronic hypoxic rats, development of PHT was assessed by right ventricular hypertrophy (LV+S/RV; PHT: 4,24±0,41 vs normoxia: 8,2±0,05 n=4–5, p<0.05), polycythemia (hematocrit: PHT: 58,7±1,4 vs normoxia: 40,2±0,8 n=4, p<0.05) and increased lung baseline perfusion pressure (PHT: 3,37± 0,46 mmHg vs normoxia: 1,58±0,19 mmHg, n=8–10 p<0.05). In PHT group rats, IMD/AM2 (10 −9 –3×10 −7 M) and ACh (10 −8 –10 −5 M) cumulatively relaxed U46619 (10 −9 –6×10 −8 M) precontracted main pulmonary artery rings and they were not different from their normoxic controls ( Table 1 , p>0.05). These responses were blocked by L‐NAME (10 −4 M) in each group ( Table 1 , p<0.05). Moreover, bolus injections (2μg/100μl) of IMD/AM2 and ACh decreased perfusion pressure similarly both in isolated buffer perfused PHT or normoxic rat lungs ( Table 2 , p>0.05). These vasodilations were still NO mediated since they were also blocked by L‐NAME (10 −4 M; Table 2 , p<0.05). Vascular smooth muscle response to papaverine (10 −4 M or 1.8 μg bolus) did not alter by chronic hypoxia in all experimental groups ( Table 1 and 2 , p>0.05). These results firstly suggest that endothelium function remains intact in PHT. Secondly, there is no evidence for a shift in IMD/AM2 receptor coupling mechanism due to PHT. In conclusion, IMD is a promising potent therapeutic agent as adrenomedullin in vasodilator therapy of PHT. Support or Funding Information The vasodilatory responses of IMD/AM2 and ACh in U46619 precontracted normoxic and chronic hypoxia induced pulmonary hypertensive (PHT) rat main pulmonary artery rings. Normoxia (Emax) PHT (Emax) n IMD/AM2 (3×10 −7 M) 43,1±3,8 40±2,8 3–4 IMD/AM2 (3×10 −7 M) + L‐NAME (10 −4 M) 9,1±1,1 10,5±0,5 2–3 ACh (10 −5 M) 68,6±6 68,3±3,2 3 ACh (10 −5 M) +L‐NAME (10 −4 M) 11±2,1 12,3±1,6 2–3 Papaverine (10 −4 M) 98±5,2 96±2,5 2–3 The vasodilatory responses to bolus injections of IMD/AM2 and ACh when perfussion pressure was raised by U46619 in isolated normoxic or chronic hypoxia induced pulmonary hypertensive (PHT) rat lungs. Normoxia PHT n IMD/AM2 (2 μg/100 μl) 27,8±2,5 30,87±1,9 6–8 IMD/AM2 (2 μg/100 μl) +L‐NAME) (10 −4 M) 6,83±3,3 11,72±1,7 3–5 ACh (2 μg/100 μl) 23,44±5,4 30,21±4,1 6–7 ACh (2 μg/100 μl) + L‐NAME(10 −4 M) 10±4,7 12,10±1,1 4–6 Papaverine (1,8 μg/100 μl) 70,27±5,5 78,93±4,3 6–7

[Changes of Intermedin/adrenomedullin 2 and Its Receptors in the Right Ventricle of Rats with Chronic Hypoxic Pulmonary Hypertension].

[Expression of Adrenomedullin and Its Receptor in Lungs of Rats with Hypoxia-Induced Pulmonary Hypertension].

Effect of Adrenomedullin on Proadrenomedullin N-terminal 20-Peptide and Hypoxic Pulmonary Vascular Structural Remodeling in Rats

Alteration of proadrenomedullin N-terminal 20-peptide in rats with chronic hypoxic pulmonary hypertension

[Effect of Adrenomedullin 1-50 on Chronic Hypoxic Pulmonary Hypertension in Rats].

Roles and Signal Pathways of Adrenomedullin and Proadrenomedullin N-terminal 20 Peptide in Pulmonary Hypertension Due to High Pulmonary Blood Flow in Rat

Chronic administration of adrenomedullin attenuates hypoxic pulmonary vascular structural remodeling and inhibits proadrenomedullin N-terminal 20-peptide production in rats.

The Acute Inhibitory Effect of Adrenomedullin on Hypoxia-Induced Pulmonary Hypertension in Rats

Adrenomedullin Relieves the Pulmonary Hypertension in Hypoxic Rats

Intermedin/Adrenomedullin 2 (IMD/AM2) is a potent vasodilator in chronic hypoxia induced pulmonary hypertensive isolated rat lungs

Roles and Signal Pathways of Adrenomedullin and Adrenotensin in Pulmonary Remodeling Due to Left to Right Shunt in Rats

Changes of adrenomedullin and receptor activity modifying protein 2 (RAMP2) in myocardium and aorta in rats with isoproterenol-induced myocardial ischemia

[Adrenomedullin Alleviates Collagen Accumulation in Pulmonary Arteries of Rats with Hypoxic Pulmonary Hypertension].

Upregulated Expression of Intermedin and Its Receptor in the Myocardium and Aorta in Spontaneously Hypertensive Rats

Hypertension Induced by Nitric Oxide Synthase Inhibitor Increases Responsiveness of Ventricular Myocardium and Aorta of Rat Tissue to Adrenomedullin Stimulation in Vitro.

Changes in Adrenomedullin and Receptor Activity-Modifying Protein 2 Mrna in Myocardium and Vessels During L-NNA-induced Hypertension in Rats

[Alterations of Proadrenomedullin N-terminal 20-Peptide in Rats with Pulmonary Hypertension Induced by High Pulmonary Blood Flow].

Differential Expression of Components of the Cardiomyocyte Adrenomedullin/Intermedin Receptor System following Blood Pressure Reduction in Nitric Oxide-Deficient Hypertension

Change of Different Active Peptide Fragments Derived from Proadrenomedullin in Pulmonary Hypertension Rats' Lung

Expression and Role of Adrenomedullin and Its Receptor in Patients with Chronic Obstructive Pulmonary Disease.

Levels of Adrenomedullin and Proadrenomedullin N-terminal 20 Peptide in Myocardium and Aorta of Spontaneously Hypertensive Rats and Wistar-Kyoto Rats.